KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Free Cash Flow (2016 - 2025)

Globus Medical's Free Cash Flow history spans 15 years, with the latest figure at $248.6 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 149.3% year-over-year to $248.6 million; the TTM value through Dec 2025 reached $740.0 million, up 82.62%, while the annual FY2025 figure was $740.0 million, 82.62% up from the prior year.
  • Free Cash Flow reached $248.6 million in Q4 2025 per GMED's latest filing, down from $318.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $318.9 million in Q3 2025 to a low of -$2.7 million in Q2 2022.
  • Average Free Cash Flow over 5 years is $91.2 million, with a median of $54.1 million recorded in 2021.
  • Peak YoY movement for Free Cash Flow: plummeted 104.7% in 2022, then surged 1421.45% in 2023.
  • A 5-year view of Free Cash Flow shows it stood at $111.6 million in 2021, then grew by 0.63% to $112.3 million in 2022, then decreased by 7.76% to $103.5 million in 2023, then dropped by 3.7% to $99.7 million in 2024, then skyrocketed by 149.3% to $248.6 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Free Cash Flow are $248.6 million (Q4 2025), $318.9 million (Q3 2025), and $5.2 million (Q2 2025).